-
Mashup Score: 0High cost and demand for old cancer drug sparks crisis - 1 year(s) ago
Experts have voiced alarm at the scarcity and cost of fludarabine, an old drug deemed crucial to cellular therapy for leukemia.
Source: www.mdedge.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1
A drug discovered at The Institute of Cancer Research that could counteract drug resistance in patients with cancers including acute myeloid leukaemia has entered a phase I clinical trial at The Royal Marsden NHS Foundation Trust.
Source: www.icr.ac.ukCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Good news! A #CancerDrug discovered here at the ICR has entered a phase I #ClinicalTrial at the @royalmarsdenNHS – and could counteract drug resistance in patients with cancers including acute myeloid #leukaemia. ➡️ https://t.co/8RZVaptv87 https://t.co/tzs5Pw5xFC
-
-
Mashup Score: 0Is FDA Getting It Right on Cancer Drug Approvals? - 3 year(s) ago
Two studies look at how the U.S. stacks up against Britain, Canada
Source: www.medpagetoday.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Not every #cancerdrug approved by the FDA receives approval elsewhere, according to two studies in @JAMAInternalMed. @oncology_bg @VPrasadMDMPH #oncotwitter https://t.co/lriWXIQDiA
-
-
Mashup Score: 6Is FDA Getting It Right on Cancer Drug Approvals? - 3 year(s) ago
Two studies look at how the U.S. stacks up against Britain, Canada
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Not every #cancerdrug approved by the FDA receives approval elsewhere, according to two studies in @JAMAInternalMed. @oncology_bg @VPrasadMDMPH #oncotwitter https://t.co/nPPHt1caPg
-
-
Mashup Score: 0Cyteir adds $80M to steer to Phase 2 with lead cancer drug, then maybe an IPO - MedCity News - 3 year(s) ago
Phase 2 testing of Cyteir’s lead cancer drug candidate later is slated to start later this year. The Series C round of funding includes crossover investors, whose involvement is a sign a biotech is preparing for an IPO.
Source: MedCity NewsCategories: General Medicine News, Latest HeadlinesTweet-
Cyteir adds $80M to steer to Phase 2 with lead cancer drug, then maybe an #IPO, writes @frankvinluan @medcitynews #cancerdrug #Funding https://t.co/bUWK94wOUS
-
-
Mashup Score: 0‎ASCO in Action Podcast: Drug Repository Programs Address High Costs, Access and Waste Issues for Patients with Cancer on Apple Podcasts - 4 year(s) ago
‎Show ASCO in Action Podcast, Ep Drug Repository Programs Address High Costs, Access and Waste Issues for Patients with Cancer – May 13, 2020
Source: Apple PodcastsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🎧 On the ASCO in Action #podcast, @RayPageDOPhD discusses how drug repository programs can help people access #cancerdrug treatments, provided appropriate patient safeguards are in place https://t.co/5PEoZKd8dR
-
#High cost and demand for old #CancerDrug sparks crisis 👉https://t.co/mYKsv0hK9q @MDedgeHemOnc @DotingaRandy #Fludarabine https://t.co/pVY97RvtJE